Yeon Ho Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yeon Ho Park has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Doojin Kim
Department of Surgery, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Korea
5 shared publications - Doo-Ho Lee
Gachon University Gil Medical Center, Gachon University College of Medicine
3 shared publications - Sang Tae Choi
Department of Surgery, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Korea
3 shared publications - Jaehun Yang
Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
2 shared publications - Kwang Gi Kim
Gachon University Gil Medical Center
2 shared publications - Won-Suk Lee
Department of Surgery Gil Medical Center, College of Medicine, Gachon University Incheon Republic of Korea
2 shared publications
Latest Publications
- Open Access
- 30 October 2025
- Published by Bentham Science Publishers Ltd. in Current Medical Imaging
- Vol. 21, 1-9
Artificial Intelligence-based Liver Volume Measurement using Preoperative and Postoperative CT Images
Introduction: Accurate liver volumetry is crucial for hepatectomy. In this study, we developed and validated a deep learning system for automated liver volumetry in patients undergoing hepatectomy, both preoperatively and at 7 days and 3 months postoperatively. Methods: A 3D U-Net model was trained on CT images from three time points using a five-fold cross-validation approach. Model performance was assessed with standard metrics and comparatively evaluated across the time points. Results: The model achieved a mean Dice Similarity Coefficient (DSC) of 94.31% (preoperative: 94.91%; 7-day post-operative: 93.45%; 3-month postoperative: 94.57%) and a mean recall of 96.04%. The volumetric difference between predicted and actual volumes was 1.01 ± 0.06% preoperatively, compared to 1.04 ± 0.03% at other time points (p < 0.05). Discussion: This study demonstrates a novel capability to automatically track post-hepatectomy regeneration using AI, offering significant potential to enhance surgical planning and patient monitoring. A key limitation, however, was that the direct correlation with clinical outcomes was not assessed due to constraints of the current dataset. Therefore, future studies using larger, multi-center datasets are essential to validate the model's clinical and prognostic utility. Conclusion: The developed artificial intelligence model successfully and accurately measured liver volumes across three critical post-hepatectomy time points. These findings support the use of this automated technology as a precise and reliable tool to assist in surgical decision-making and postoperative assessment, providing a strong foundation for enhancing patient care.
- 30 October 2025
- Published by Bentham Science Publishers Ltd. in Current Medical Imaging
- Vol. 21, 1-9
Open AccessArtificial Intelligence-based Liver Volume Measurement using Preoperative and Postoperative CT Images
Introduction: Accurate liver volumetry is crucial for hepatectomy. In this study, we developed and validated a deep learning system for automated liver volumetry in patients undergoing hepatectomy, both preoperatively and at 7 days and 3 months postoperatively. Methods: A 3D U-Net model was trained on CT images from three time points using a five-fold cross-validation approach. Model performance was assessed with standard metrics and comparatively evaluated across the time points. Results: The model achieved a mean Dice Similarity Coefficient (DSC) of 94.31% (preoperative: 94.91%; 7-day post-operative: 93.45%; 3-month postoperative: 94.57%) and a mean recall of 96.04%. The volumetric difference between predicted and actual volumes was 1.01 ± 0.06% preoperatively, compared to 1.04 ± 0.03% at other time points (p < 0.05). Discussion: This study demonstrates a novel capability to automatically track post-hepatectomy regeneration using AI, offering significant potential to enhance surgical planning and patient monitoring. A key limitation, however, was that the direct correlation with clinical outcomes was not assessed due to constraints of the current dataset. Therefore, future studies using larger, multi-center datasets are essential to validate the model's clinical and prognostic utility. Conclusion: The developed artificial intelligence model successfully and accurately measured liver volumes across three critical post-hepatectomy time points. These findings support the use of this automated technology as a precise and reliable tool to assist in surgical decision-making and postoperative assessment, providing a strong foundation for enhancing patient care.
- Open Access
- 23 April 2024
- Published by The Korean Association of Hepato-Biliary-Pancreatic Surgery in Annals of Hepato-Biliary-Pancreatic Surgery
- Vol. 28 (3) , 364-370
Pancreatic volume and endocrine function changes following pancreaticoduodenectomy for peri-ampullary neoplasms: A retrospective single-center study utilizing pancreas volumetry
Jaehun Yang, Yeon Ho Park, Doojin Kim, Doo-Ho Lee. Ann Hepatobiliary Pancreat Surg 2024;28:364-70. https://doi.org/10.14701/ahbps.24-004
- 23 April 2024
- Published by The Korean Association of Hepato-Biliary-Pancreatic Surgery in Annals of Hepato-Biliary-Pancreatic Surgery
- Vol. 28 (3) , 364-370
Open AccessPancreatic volume and endocrine function changes following pancreaticoduodenectomy for peri-ampullary neoplasms: A retrospective single-center study utilizing pancreas volumetry
Jaehun Yang, Yeon Ho Park, Doojin Kim, Doo-Ho Lee. Ann Hepatobiliary Pancreat Surg 2024;28:364-70. https://doi.org/10.14701/ahbps.24-004
- Open Access
- 21 July 2022
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
- Vol. 41 (5) , 623-634
Antithymocyte globulin versus basiliximab induction for kidney transplantation in elderly patients: matched analysis within the Korean multicentric registry
Background: Basiliximab (BSX) and antithymocyte globulins (ATGs), are two major immunosuppressive agents commonly used as induction therapy for kidney transplant (KT) recipients. The superiority of ATG over BSX has not been well established, especially in elderly KT recipients with low immunological risk. Methods: A total of 847 elderly (≥60 years old), low-risk KT patients in the Korean Organ Transplantation Registry were propensity score-matched at a 1:2 ratio and compared according to ATG or BSX induction therapy. The primary outcome was patient and graft survival and biopsy-proven acute cellular rejection. The secondary outcome was graft function, BK virus nephropathy, infection, cancer, new-onset diabetes mellitus after transplantation (NODAT), and delayed graft function. Results: In total, 165 patients in the ATG group were matched with 298 patients in the BSX group with average ages of 64.3 and 64.2 years, respectively. During a follow-up of 28.5 ± 10.4 months, the cumulative probabilities of death-censored graft failure at 3 years posttransplantation were 1.3% and 1.4% in ATG and BSX groups, respectively, without a significant difference (p = 0.72). The cumulative probability of NODAT at 3 years posttransplantation was significantly higher in the BSX group (35.6% vs. 21.6%, p = 0.02). The median tacrolimus trough level was significantly lower at 6 months after KT in the ATG group (5.7 ng/mL vs. 6.4 ng/mL, p = 0.001). There were no differences in the other evaluated outcomes. Conclusion: Compared with BSX, in elderly, low-risk KT patients, ATG reduced tacrolimus and steroid requirements without differences in all-cause mortality, rejection, or infection, resulting in a reduced NODAT incidence.
- 21 July 2022
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
- Vol. 41 (5) , 623-634
Open AccessAntithymocyte globulin versus basiliximab induction for kidney transplantation in elderly patients: matched analysis within the Korean multicentric registry
Background: Basiliximab (BSX) and antithymocyte globulins (ATGs), are two major immunosuppressive agents commonly used as induction therapy for kidney transplant (KT) recipients. The superiority of ATG over BSX has not been well established, especially in elderly KT recipients with low immunological risk. Methods: A total of 847 elderly (≥60 years old), low-risk KT patients in the Korean Organ Transplantation Registry were propensity score-matched at a 1:2 ratio and compared according to ATG or BSX induction therapy. The primary outcome was patient and graft survival and biopsy-proven acute cellular rejection. The secondary outcome was graft function, BK virus nephropathy, infection, cancer, new-onset diabetes mellitus after transplantation (NODAT), and delayed graft function. Results: In total, 165 patients in the ATG group were matched with 298 patients in the BSX group with average ages of 64.3 and 64.2 years, respectively. During a follow-up of 28.5 ± 10.4 months, the cumulative probabilities of death-censored graft failure at 3 years posttransplantation were 1.3% and 1.4% in ATG and BSX groups, respectively, without a significant difference (p = 0.72). The cumulative probability of NODAT at 3 years posttransplantation was significantly higher in the BSX group (35.6% vs. 21.6%, p = 0.02). The median tacrolimus trough level was significantly lower at 6 months after KT in the ATG group (5.7 ng/mL vs. 6.4 ng/mL, p = 0.001). There were no differences in the other evaluated outcomes. Conclusion: Compared with BSX, in elderly, low-risk KT patients, ATG reduced tacrolimus and steroid requirements without differences in all-cause mortality, rejection, or infection, resulting in a reduced NODAT incidence.
- Open Access
- 7 October 2021
- Published by The Korean Society for Transplantation in Korean Journal of Transplantation
- Vol. 35 (1) , S132
The impact of the multiple bile ducts on postoperative biliary complications in living donor liver transplantation: a single center experience
Doojin Kim, Doo-Hoo Lee, Sang-Tae Choi, Yeon Ho Park. Korean J Transplant 2021;35:132. https://doi.org/10.4285/ATW2021.PO-1279
- 7 October 2021
- Published by The Korean Society for Transplantation in Korean Journal of Transplantation
- Vol. 35 (1) , S132
Open AccessThe impact of the multiple bile ducts on postoperative biliary complications in living donor liver transplantation: a single center experience
Doojin Kim, Doo-Hoo Lee, Sang-Tae Choi, Yeon Ho Park. Korean J Transplant 2021;35:132. https://doi.org/10.4285/ATW2021.PO-1279
- Open Access
- 1 January 2021
- Published by The Korean Surgical Society in Annals of Surgical Treatment and Research
- Vol. 101 (6) , 360-367
The impact of Model for End-Stage Liver Disease score on deceased donor liver transplant outcomes in low volume liver transplantation center: a retrospective and single-center study
Lee DH, et al. Ann Surg Treat Res. 2021 Dec;101(6):360-367. https://doi.org/10.4174/astr.2021.101.6.360
- 1 January 2021
- Published by The Korean Surgical Society in Annals of Surgical Treatment and Research
- Vol. 101 (6) , 360-367
Open AccessThe impact of Model for End-Stage Liver Disease score on deceased donor liver transplant outcomes in low volume liver transplantation center: a retrospective and single-center study
Lee DH, et al. Ann Surg Treat Res. 2021 Dec;101(6):360-367. https://doi.org/10.4174/astr.2021.101.6.360
- Open Access
- 31 October 2020
- Published by The Korean Society of Medical Informatics in Healthcare Informatics Research
- Vol. 26 (4) , 321-327
Distribution and Characteristics of Pancreatic Volume Using Computed Tomography Volumetry
Changes in the pancreatic volume (PV) are useful as potential clinical markers for some pancreatic-related diseases. The objective of this study was to measure the volume of the pancreas using computed tomography (CT) volumetry and to evaluate the relationships between sex, age, body mass index (BMI), and sarcopenia. We retrospectively analyzed the abdominal CT scans of 1,003 subjects whose ages ranged between 10 and 90 years. The pancreas was segmented manually to define the region of interest (ROI) based on CT images, and then the PVs were measured by counting the voxels in all ROIs within the pancreas boundary. Sarcopenia was identified by examination of CT images that determined the crosssectional area of the skeletal muscle around the third lumbar vertebra. The mean volume of the pancreas was 62.648 ± 19.094 cm3. The results indicated a negative correlation between the PV and age. There was a positive correlation between the PV and BMI for both sexes, females, and males (r = 0.343, p < 0.001; r = 0.461, p < 0.001; and r = 0.244, p < 0.001, respectively). Additionally, there was a positive correlation between the PV and sarcopenia for females (r = 0.253, p < 0.001) and males (r = 0.200, p < 0.001). CT pancreas volumetry results may help physicians follow up or predict conditions of the pancreas after interventions for pancreatic-related disease in the future.
- 31 October 2020
- Published by The Korean Society of Medical Informatics in Healthcare Informatics Research
- Vol. 26 (4) , 321-327
Open AccessDistribution and Characteristics of Pancreatic Volume Using Computed Tomography Volumetry
Changes in the pancreatic volume (PV) are useful as potential clinical markers for some pancreatic-related diseases. The objective of this study was to measure the volume of the pancreas using computed tomography (CT) volumetry and to evaluate the relationships between sex, age, body mass index (BMI), and sarcopenia. We retrospectively analyzed the abdominal CT scans of 1,003 subjects whose ages ranged between 10 and 90 years. The pancreas was segmented manually to define the region of interest (ROI) based on CT images, and then the PVs were measured by counting the voxels in all ROIs within the pancreas boundary. Sarcopenia was identified by examination of CT images that determined the crosssectional area of the skeletal muscle around the third lumbar vertebra. The mean volume of the pancreas was 62.648 ± 19.094 cm3. The results indicated a negative correlation between the PV and age. There was a positive correlation between the PV and BMI for both sexes, females, and males (r = 0.343, p < 0.001; r = 0.461, p < 0.001; and r = 0.244, p < 0.001, respectively). Additionally, there was a positive correlation between the PV and sarcopenia for females (r = 0.253, p < 0.001) and males (r = 0.200, p < 0.001). CT pancreas volumetry results may help physicians follow up or predict conditions of the pancreas after interventions for pancreatic-related disease in the future.
- Open Access
- 15 March 2019
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in Journal of Pathology and Translational Medicine
- Vol. 53 (2) , 112-118
Squamous Cell Carcinoma of the Extrahepatic Common Hepatic Duct
We report a rare case of hilar squamous cell carcinoma. A 62-year-old Korean woman complaining of nausea was referred to our hospital. Her biliary computed tomography revealed a 28 mm-sized protruding solid mass in the proximal common bile duct. The patient underwent left hemihepatectomy with S1 segmentectomy and segmental excision of the common bile duct. Microscopically, the tumor was a moderately differentiated squamous cell carcinoma of the extrahepatic bile duct, without any component of adenocarcinoma or metaplastic portion in the biliary epithelium. Immunohistochemically, the tumor was positive for cytokeratin (CK) 5/6, CK19, p40, and p63. Squamous cell carcinoma of the extrahepatic bile duct is rare. To date, only 24 cases of biliary squamous cell carcinomas have been reported. Here, we provide a clinicopathologic review of previously reported extrahepatic bile duct squamous cell carcinomas.
- 15 March 2019
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in Journal of Pathology and Translational Medicine
- Vol. 53 (2) , 112-118
Open AccessSquamous Cell Carcinoma of the Extrahepatic Common Hepatic Duct
We report a rare case of hilar squamous cell carcinoma. A 62-year-old Korean woman complaining of nausea was referred to our hospital. Her biliary computed tomography revealed a 28 mm-sized protruding solid mass in the proximal common bile duct. The patient underwent left hemihepatectomy with S1 segmentectomy and segmental excision of the common bile duct. Microscopically, the tumor was a moderately differentiated squamous cell carcinoma of the extrahepatic bile duct, without any component of adenocarcinoma or metaplastic portion in the biliary epithelium. Immunohistochemically, the tumor was positive for cytokeratin (CK) 5/6, CK19, p40, and p63. Squamous cell carcinoma of the extrahepatic bile duct is rare. To date, only 24 cases of biliary squamous cell carcinomas have been reported. Here, we provide a clinicopathologic review of previously reported extrahepatic bile duct squamous cell carcinomas.
- Open Access
- 31 December 2018
- Published by The Korean Society for Vascular Surgery in Vascular Specialist International
- Vol. 34 (4) , 88-93
Comparison of Outcomes of Hybrid and Surgical Correction forDe NovoArteriovenous Graft Occlusion
This study aimed to compare surgical revisions and balloon angioplasty after surgical thrombectomy on thrombosed dialysis access as a first event. Records of patients undergoing creation of arteriovenous grafts (AVGs) at the Gachon University Gil Medical Center between March 2008 and February 2016 were reviewed. Among them, patients who underwent treatment on first-time thrombotic occlusion after AVG creation were identified. Outcomes were primary, primary-assisted, and secondary patency. The patency was generated using the Kaplan-Meier method, and patency rates were compared by log-rank test. A total of 59 de novo interventions (n=26, hybrid interventions; n=33, surgical revisions) for occlusive AVGs were identified. The estimated 1-year primary patency rates were 47% and 30% in the surgery and hybrid groups, respectively. The estimated primary patency rates were not different between the two groups (log-rank test, P=0.73). The Kaplan-Meier estimates of 6 and 12 months for primary-assisted patency rates were 68% and 57% in the surgery group and 56% and 56% in the hybrid group. The Kaplan-Meier estimates of 12 and 24 months secondary patency rates were 90% and 71% in the surgery group and 79% and 62% in the hybrid group. There were no differences in the estimated primary-assisted and secondary patency rates between the two groups. Our results showed no significant difference between the two groups in terms of primary patency (P=0.73), primary-assisted patency (P=0.85), and secondary patency (P=0.78). However, percutaneous transluminal angioplasty can give more therapeutic options for both surgeons and patients.
- 31 December 2018
- Published by The Korean Society for Vascular Surgery in Vascular Specialist International
- Vol. 34 (4) , 88-93
Open AccessComparison of Outcomes of Hybrid and Surgical Correction forDe NovoArteriovenous Graft Occlusion
This study aimed to compare surgical revisions and balloon angioplasty after surgical thrombectomy on thrombosed dialysis access as a first event. Records of patients undergoing creation of arteriovenous grafts (AVGs) at the Gachon University Gil Medical Center between March 2008 and February 2016 were reviewed. Among them, patients who underwent treatment on first-time thrombotic occlusion after AVG creation were identified. Outcomes were primary, primary-assisted, and secondary patency. The patency was generated using the Kaplan-Meier method, and patency rates were compared by log-rank test. A total of 59 de novo interventions (n=26, hybrid interventions; n=33, surgical revisions) for occlusive AVGs were identified. The estimated 1-year primary patency rates were 47% and 30% in the surgery and hybrid groups, respectively. The estimated primary patency rates were not different between the two groups (log-rank test, P=0.73). The Kaplan-Meier estimates of 6 and 12 months for primary-assisted patency rates were 68% and 57% in the surgery group and 56% and 56% in the hybrid group. The Kaplan-Meier estimates of 12 and 24 months secondary patency rates were 90% and 71% in the surgery group and 79% and 62% in the hybrid group. There were no differences in the estimated primary-assisted and secondary patency rates between the two groups. Our results showed no significant difference between the two groups in terms of primary patency (P=0.73), primary-assisted patency (P=0.85), and secondary patency (P=0.78). However, percutaneous transluminal angioplasty can give more therapeutic options for both surgeons and patients.
- 20 May 2017
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 35 (15_suppl) , e15047
The effect of post-operative chemotherapy and prognostic factors for colorectal cancer liver: Only metastasis (CRLM) after R0 or R1 resection.
E15047 Background:Complete removal of all known tumor is the most important indicator that correlated with survival of CRLM. However, the role of post-operative chemotherapy for resected CRLM has not yet been clarified. We evaluate the role of post-operative chemotherapy in setting for curatively resected CRLM. Methods:We reviewed all 164 patients (pts) underwent resection of CRLM in our institute between Nov 2002 and Apr 2016, and selected 109 pts underwent R0 or R1 resection of primary and CRLM. Pts with R2, extra-hepatic, and non-regional lymph nodes metastasis were excluded. Kaplan-Meier and log-rank test was used for survival analysis. Results:The median age was 62.9 (29-88) years; male (70%). Primary tumor locations were right (24.8%), left (52.3%), and rectum (22.9%). The median number and total sum of maximum diameter of CRLM were 2 (1-13) and 4.2 (0.6-19.7) cm, respectively. Eight-one pts (74%) underwent R0 resection of both primary tumor and CRLM and 84 pts (77%) received post-operative chemotherapy (66 pts with cytotoxic chemotherapy only, 18 with cytotoxic chemotherapy with biologics). With a median follow-up of 35.7 months, median overall survival was 57.0 months, and disease free survival (DFS) was 13.7 months. Univariate analysis revealed that node-stage of primary tumor ( p= 0.024), preoperative CEA (≤ 5 v > 5 ng/ml)( p= 0.002), total sum of maximum diameter (≤ 5 v > 5 cm)( p= 0.013), and complete resection of tumor (R0 v R1)( p< 0.001) were significantly associated longer DFS. Post-operative chemotherapy did not show difference of DFS (median 7.5 months with no treatment, 14.2 months with cytotoxic chemotherapy, and 14.8 months with biologics, p= 0.739). In multivariate analysis, complete resection of tumor (Hazard Ratio (HR); 0.381, 95% confidence interval (CI); 0.215-0.646, p= 0.001) and preoperative CEA level (HR; 0.453, 95% CI; 1.015-3.621; p= 0.045) was independent factor for longer DFS. Conclusions: The post-operative chemotherapy for CRLM after R0 or R1 resection shows no difference in survival. Complete resection with negative surgical margin is the most important indicator for longer survival.
- 20 May 2017
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 35 (15_suppl) , e15047
The effect of post-operative chemotherapy and prognostic factors for colorectal cancer liver: Only metastasis (CRLM) after R0 or R1 resection.
E15047 Background:Complete removal of all known tumor is the most important indicator that correlated with survival of CRLM. However, the role of post-operative chemotherapy for resected CRLM has not yet been clarified. We evaluate the role of post-operative chemotherapy in setting for curatively resected CRLM. Methods:We reviewed all 164 patients (pts) underwent resection of CRLM in our institute between Nov 2002 and Apr 2016, and selected 109 pts underwent R0 or R1 resection of primary and CRLM. Pts with R2, extra-hepatic, and non-regional lymph nodes metastasis were excluded. Kaplan-Meier and log-rank test was used for survival analysis. Results:The median age was 62.9 (29-88) years; male (70%). Primary tumor locations were right (24.8%), left (52.3%), and rectum (22.9%). The median number and total sum of maximum diameter of CRLM were 2 (1-13) and 4.2 (0.6-19.7) cm, respectively. Eight-one pts (74%) underwent R0 resection of both primary tumor and CRLM and 84 pts (77%) received post-operative chemotherapy (66 pts with cytotoxic chemotherapy only, 18 with cytotoxic chemotherapy with biologics). With a median follow-up of 35.7 months, median overall survival was 57.0 months, and disease free survival (DFS) was 13.7 months. Univariate analysis revealed that node-stage of primary tumor ( p= 0.024), preoperative CEA (≤ 5 v > 5 ng/ml)( p= 0.002), total sum of maximum diameter (≤ 5 v > 5 cm)( p= 0.013), and complete resection of tumor (R0 v R1)( p< 0.001) were significantly associated longer DFS. Post-operative chemotherapy did not show difference of DFS (median 7.5 months with no treatment, 14.2 months with cytotoxic chemotherapy, and 14.8 months with biologics, p= 0.739). In multivariate analysis, complete resection of tumor (Hazard Ratio (HR); 0.381, 95% confidence interval (CI); 0.215-0.646, p= 0.001) and preoperative CEA level (HR; 0.453, 95% CI; 1.015-3.621; p= 0.045) was independent factor for longer DFS. Conclusions: The post-operative chemotherapy for CRLM after R0 or R1 resection shows no difference in survival. Complete resection with negative surgical margin is the most important indicator for longer survival.